Daniel Castellano Selected Research

Daniel Castellano Research Topics

Disease

91	Neoplasms (Cancer) 05/2024 - 12/2002
62	Renal Cell Carcinoma (Grawitz Tumor) 11/2023 - 03/2009
44	Carcinoma (Carcinomatosis) 03/2024 - 12/2011
34	Prostatic Neoplasms (Prostate Cancer) 03/2024 - 01/2011
19	Disease Progression 03/2024 - 12/2006
17	Neoplasm Metastasis (Metastasis) 03/2024 - 03/2009
11	Urinary Bladder Neoplasms (Bladder Cancer) 01/2023 - 01/2013
7	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2024 - 03/2011
7	Fatigue 01/2021 - 12/2011
6	Pain (Aches) 02/2024 - 03/2014
4	Breast Neoplasms (Breast Cancer) 03/2024 - 09/2009
4	Body Weight (Weight, Body) 03/2024 - 11/2015
4	Kidney Neoplasms (Kidney Cancer) 01/2023 - 02/2016
4	Neutropenia 11/2022 - 01/2017
4	Pneumonia (Pneumonitis) 01/2022 - 05/2016
4	Asthenia 10/2021 - 03/2013
4	Diarrhea 10/2021 - 03/2013
4	Hypertension (High Blood Pressure) 12/2020 - 12/2011
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 01/2005
3	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 01/2020 - 01/2017
3	Exanthema (Rash) 10/2016 - 01/2013
3	Carcinogenesis 07/2015 - 03/2011
2	Penile Neoplasms (Penile Cancer) 05/2024 - 12/2023
2	Urologic Neoplasms (Urological Cancer) 02/2024 - 01/2019
2	Adenocarcinoma 11/2023 - 01/2019
2	Bronchiolitis Obliterans Syndrome 11/2023 - 05/2023
2	Circulating Neoplastic Cells 03/2023 - 12/2018
2	Glioblastoma (Glioblastoma Multiforme) 01/2022 - 06/2015
2	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 01/2016
2	Carcinoid Tumor (Carcinoid) 01/2022 - 09/2013
2	Hepatitis 12/2020 - 11/2019
2	Autoimmune Diseases (Autoimmune Disease) 10/2020 - 01/2019
2	Stomatitis 01/2020 - 01/2013

Drug/Important Bio-Agent (IBA)

26	Sunitinib (Sutent)FDA Link 06/2022 - 08/2009
24	PlatinumIBA 03/2024 - 01/2005
23	Immune Checkpoint InhibitorsIBA 12/2023 - 05/2016
22	Biomarkers (Surrogate Marker)IBA 12/2023 - 12/2006
16	atezolizumabIBA 12/2023 - 05/2016
15	Docetaxel (Taxotere)FDA Link 11/2022 - 03/2014
14	Cisplatin (Platino)FDA LinkGeneric 03/2024 - 08/2012
14	Everolimus FDA Link 01/2023 - 03/2011
12	NivolumabIBA 01/2022 - 11/2015
11	Tyrosine Kinase InhibitorsIBA 01/2023 - 03/2011
10	Prostate-Specific Antigen (Semenogelase)IBA 03/2024 - 03/2014
10	B7-H1 AntigenIBA 12/2023 - 10/2020
10	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2023 - 11/2011
8	Prednisone (Sone)FDA LinkGeneric 11/2022 - 01/2014
8	cabozantinibIBA 01/2022 - 10/2018
8	cabazitaxel FDA Link 10/2021 - 09/2014
6	pembrolizumabIBA 03/2024 - 11/2017
6	Gemcitabine FDA Link 03/2024 - 09/2003
6	enzalutamideIBA 03/2023 - 12/2019
6	vinflunineIBA 01/2022 - 10/2014
6	abirateroneIBA 01/2022 - 05/2015
6	TOR Serine-Threonine KinasesIBA 11/2020 - 09/2012
5	Carboplatin (JM8)FDA LinkGeneric 03/2024 - 01/2005
5	taxaneIBA 01/2023 - 08/2004
5	IpilimumabIBA 01/2022 - 04/2018
4	Proteins (Proteins, Gene)FDA Link 05/2024 - 03/2014
4	Androgen Receptors (Androgen Receptor)IBA 03/2024 - 01/2017
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2022 - 12/2011
4	MicroRNAs (MicroRNA)IBA 12/2022 - 01/2014
4	Abiraterone AcetateIBA 11/2022 - 10/2014
4	Monoclonal AntibodiesIBA 01/2022 - 01/2011
4	RamucirumabIBA 01/2022 - 11/2017
4	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 01/2019 - 11/2011
4	Angiogenesis InhibitorsIBA 12/2014 - 12/2006
3	enfortumab vedotinIBA 03/2024 - 01/2021
3	LigandsIBA 11/2023 - 12/2017
3	DNA (Deoxyribonucleic Acid)IBA 07/2023 - 01/2017
3	rucaparibIBA 01/2023 - 01/2022
3	Axitinib (AG 013736)IBA 01/2022 - 12/2011
3	AndrogensIBA 08/2021 - 12/2019
2	avelumabIBA 12/2023 - 10/2023
2	ibrutinibIBA 11/2023 - 05/2023
2	Agammaglobulinaemia Tyrosine KinaseIBA 11/2023 - 05/2023
2	durvalumabIBA 01/2023 - 12/2020
2	Messenger RNA (mRNA)IBA 01/2023 - 01/2017
2	Alkaline PhosphataseIBA 01/2023 - 11/2017
2	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 01/2023 - 01/2023
2	Hemoglobins (Hemoglobin)IBA 01/2023 - 05/2017
2	Hormones (Hormone)IBA 01/2023 - 01/2023
2	olaparibIBA 01/2023 - 01/2022
2	lenvatinibIBA 01/2023 - 01/2022
2	TabletsIBA 01/2022 - 11/2015
2	pazopanib FDA Link 06/2021 - 12/2017
2	InterferonsIBA 06/2021 - 06/2018
2	Interleukin-8 (Interleukin 8)IBA 06/2021 - 12/2015
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2021 - 01/2018
2	Programmed Cell Death 1 ReceptorIBA 01/2021 - 01/2019
2	ParaffinIBA 01/2020 - 01/2017

Therapy/Procedure

75	Therapeutics 05/2023 - 08/2004
34	Drug Therapy (Chemotherapy) 03/2024 - 01/2005
31	Castration 03/2024 - 11/2011
9	Immunotherapy 05/2024 - 05/2019
6	Cystectomy 01/2023 - 11/2019
5	Nephrectomy 01/2022 - 05/2017
4	Neoadjuvant Therapy 01/2023 - 08/2004
4	Aftercare (After-Treatment) 01/2023 - 11/2019
3	Radiotherapy 11/2022 - 06/2007